• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用 SimpleProbe、高分辨率熔解曲线和焦磷酸测序核酸分析技术鉴定生物威胁剂中的环丙沙星耐药性:炭疽芽孢杆菌、鼠疫耶尔森菌和土拉弗朗西斯菌。

Identification of ciprofloxacin resistance by SimpleProbe, High Resolution Melt and Pyrosequencing nucleic acid analysis in biothreat agents: Bacillus anthracis, Yersinia pestis and Francisella tularensis.

机构信息

Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.

出版信息

Mol Cell Probes. 2010 Jun;24(3):154-60. doi: 10.1016/j.mcp.2010.01.003. Epub 2010 Jan 25.

DOI:10.1016/j.mcp.2010.01.003
PMID:20100564
Abstract

The potential for genetic modification of biological warfare agents makes rapid identification of antibiotic resistant strains critical for the implementation of suitable infection control measures. The fluorinated quinolone, ciprofloxacin, is an antibiotic effective for treating bacterial infections by inhibiting the enzyme activity of the DNA type II topoisomerases DNA gyrase and topoisomerase IV. The genes that encode the subunits of DNA gyrase (gyrA and gyrB) and topo IV (par C and parE) contain hotspots within an area known as the quinolone resistance-determining region (QRDR). Base pair changes within this region give rise to mutations that cause resistance to the antibiotic by altering amino acids within the enzymes. Ciprofloxacin-resistant (cipro(r)) strains of Bacillus anthracis, Yersinia pestis, and Francisella tularensis with one or more known mutations within the QRDR of gyrA, gyrB, parC, and parE genes were tested with SimpleProbe and High Resolution Melt (HRM) dye chemistries and Pyrosequencing genetic analysis to evaluate the ability to rapidly detect ciprofloxacin-induced mutations. While SimpleProbe and Pyrosequencing successfully identified all known mutants, the HRM assay identified all but those resulting from G<-->C or A<-->T substitutions.

摘要

生物战剂的遗传修饰潜力使得快速鉴定抗生素耐药菌株对于实施适当的感染控制措施至关重要。氟喹诺酮类药物环丙沙星是一种有效的抗生素,通过抑制 DNA 拓扑异构酶 II 型(gyrase 和拓扑异构酶 IV)的酶活性来治疗细菌感染。编码 DNA 拓扑异构酶(gyrA 和 gyrB)和拓扑异构酶 IV(parC 和 parE)亚基的基因在称为喹诺酮类药物耐药决定区(QRDR)的区域内存在热点。该区域内的碱基对变化导致抗生素耐药性的出现,从而改变酶内的氨基酸。用 SimpleProbe 和高分辨率熔解(HRM)染料化学法和焦磷酸测序遗传分析对炭疽芽胞杆菌、鼠疫耶尔森菌和土拉弗朗西斯菌的环丙沙星耐药(cipro(r))菌株进行了测试,这些菌株在 gyrA、gyrB、parC 和 parE 基因的 QRDR 内有一个或多个已知突变,以评估快速检测环丙沙星诱导突变的能力。虽然 SimpleProbe 和焦磷酸测序成功地鉴定了所有已知的突变体,但 HRM 检测法除了那些由 G<-->C 或 A<-->T 取代引起的突变体外,都能识别出来。

相似文献

1
Identification of ciprofloxacin resistance by SimpleProbe, High Resolution Melt and Pyrosequencing nucleic acid analysis in biothreat agents: Bacillus anthracis, Yersinia pestis and Francisella tularensis.应用 SimpleProbe、高分辨率熔解曲线和焦磷酸测序核酸分析技术鉴定生物威胁剂中的环丙沙星耐药性:炭疽芽孢杆菌、鼠疫耶尔森菌和土拉弗朗西斯菌。
Mol Cell Probes. 2010 Jun;24(3):154-60. doi: 10.1016/j.mcp.2010.01.003. Epub 2010 Jan 25.
2
Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.DNA 回旋酶和拓扑异构酶 IV 基因突变对大肠杆菌临床分离株中环丙沙星耐药性的贡献。
Int J Antimicrob Agents. 2011 Mar;37(3):253-5. doi: 10.1016/j.ijantimicag.2010.11.022. Epub 2011 Jan 13.
3
Detection of ciprofloxacin-resistant Yersinia pestis by fluorogenic PCR using the LightCycler.使用LightCycler通过荧光定量PCR检测耐环丙沙星的鼠疫耶尔森菌
J Clin Microbiol. 2001 Oct;39(10):3649-55. doi: 10.1128/JCM.39.10.3649-3655.2001.
4
Activities of different fluoroquinolones against Bacillus anthracis mutants selected in vitro and harboring topoisomerase mutations.不同氟喹诺酮类药物对体外筛选出的携带拓扑异构酶突变的炭疽芽孢杆菌突变株的活性。
Antimicrob Agents Chemother. 2004 Aug;48(8):3024-7. doi: 10.1128/AAC.48.8.3024-3027.2004.
5
Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.铜绿假单胞菌环丙沙星耐药临床分离株中拓扑异构酶II的GyrA和GyrB亚基以及拓扑异构酶IV的ParC和ParE亚基的改变。
Int J Antimicrob Agents. 2005 Apr;25(4):290-5. doi: 10.1016/j.ijantimicag.2004.11.012.
6
An unusually high level of quinolone resistance associated with type II topoisomerase mutations in quinolone resistance-determining regions of Aeromonas caviae isolated from diarrhoeal patients.从腹泻患者中分离出的豚鼠气单胞菌,其喹诺酮耐药决定区的II型拓扑异构酶突变与异常高水平的喹诺酮耐药性相关。
Res Microbiol. 2004 Dec;155(10):827-9. doi: 10.1016/j.resmic.2004.06.008.
7
Rapid detection of gyrA and parC mutations in quinolone-resistant Salmonella enterica using Pyrosequencing technology.利用焦磷酸测序技术快速检测耐喹诺酮肠炎沙门氏菌中的gyrA和parC突变
J Microbiol Methods. 2007 Jan;68(1):163-71. doi: 10.1016/j.mimet.2006.07.006. Epub 2006 Aug 24.
8
Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003).在美国九个机构(1999 - 2003年)对左氧氟沙星敏感的肺炎链球菌临床分离株中,拓扑异构酶IV和DNA促旋酶基因单突变的发生率较低。
J Antimicrob Chemother. 2006 Mar;57(3):437-42. doi: 10.1093/jac/dki487. Epub 2006 Jan 23.
9
Resistance of different Chlamydia-like organisms to quinolones and mutations in the quinoline resistance-determining region of the DNA gyrase A- and topoisomerase-encoding genes.不同类衣原体生物对喹诺酮类药物的耐药性以及DNA促旋酶A和拓扑异构酶编码基因喹诺酮耐药决定区的突变
Int J Antimicrob Agents. 2006 Jun;27(6):541-4. doi: 10.1016/j.ijantimicag.2006.03.009. Epub 2006 May 12.
10
Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.一种哌嗪基交联环丙沙星二聚体对金黄色葡萄球菌和大肠杆菌的杀菌活性及靶点偏好性
J Antimicrob Chemother. 2006 Dec;58(6):1283-6. doi: 10.1093/jac/dkl388. Epub 2006 Sep 26.

引用本文的文献

1
Treatment of bacterial biothreat agents with a novel purified bioactive lactoferrin affects both growth and biofilm formation.用一种新型纯化生物活性乳铁蛋白治疗细菌生物威胁因子会影响其生长和生物膜形成。
Front Cell Infect Microbiol. 2025 Jun 17;15:1603689. doi: 10.3389/fcimb.2025.1603689. eCollection 2025.
2
Structure, identification and characterization of the RibD-enolase complex in .[具体物种]中RibD-烯醇酶复合物的结构、鉴定及特征分析 (原文中“in.”后面缺少具体物种信息)
bioRxiv. 2025 Mar 3:2025.03.02.641097. doi: 10.1101/2025.03.02.641097.
3
Development of Effective Medical Countermeasures Against the Main Biowarfare Agents: The Importance of Antibodies.
针对主要生物战剂的有效医学应对措施的研发:抗体的重要性
Microorganisms. 2024 Dec 18;12(12):2622. doi: 10.3390/microorganisms12122622.
4
Intracellular Experimental Evolution of Subsp. Live Vaccine Strain (LVS) to Antimicrobial Resistance.亚单位活疫苗株(LVS)的细胞内实验进化以对抗微生物药物耐药性。
ACS Infect Dis. 2023 Feb 10;9(2):308-321. doi: 10.1021/acsinfecdis.2c00483. Epub 2023 Jan 20.
5
Mutational Switch-Backs Can Accelerate Evolution of to a Combination of Ciprofloxacin and Doxycycline.突变折返可加速对环丙沙星和强力霉素联合用药的进化。
Front Microbiol. 2022 May 9;13:904822. doi: 10.3389/fmicb.2022.904822. eCollection 2022.
6
Beating the Bio-Terror Threat with Rapid Antimicrobial Susceptibility Testing.通过快速抗菌药敏试验应对生物恐怖威胁
Microorganisms. 2021 Jul 19;9(7):1535. doi: 10.3390/microorganisms9071535.
7
Structural Basis for Virulence Activation of Francisella tularensis.弗朗西斯氏土拉菌毒力激活的结构基础。
Mol Cell. 2021 Jan 7;81(1):139-152.e10. doi: 10.1016/j.molcel.2020.10.035. Epub 2020 Nov 19.
8
Evolution of Antibiotic Resistance in Surrogates of (LVS and ): Effects on Biofilm Formation and Fitness.(利什曼原虫和 )替代物中抗生素耐药性的演变:对生物膜形成和适应性的影响
Front Microbiol. 2020 Oct 30;11:593542. doi: 10.3389/fmicb.2020.593542. eCollection 2020.
9
A Survey of Antimicrobial Resistance Determinants in Category A Select Agents, Exempt Strains, and Near-Neighbor Species.A 类选择剂、豁免株和近缘种中抗菌药物耐药决定因素的调查。
Int J Mol Sci. 2020 Feb 29;21(5):1669. doi: 10.3390/ijms21051669.
10
A Mutant, Lacking the Soluble Lytic Transglycosylase Slt, Exhibits Defects in Both Growth and Virulence.缺乏可溶性溶菌转糖基酶Slt的A突变体在生长和毒力方面均表现出缺陷。
Front Microbiol. 2019 Jun 14;10:1343. doi: 10.3389/fmicb.2019.01343. eCollection 2019.